Adco Pantoprazole Iv
No structure available
This product's active ingredient could not be matched to a single known compound.
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock Ingram Critical Care (Pty) Ltd | Adco pantoprazole iv | 40mg | 440981 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adco pantoprazole iv EACH 15,0 ml SOLUTION CONTAINS :PANTOPRAZOLE SODUIM SESQUIHYDRATE EQUIVALENT TO PANTROPRAZOLE 40,0 mg | 40mgTablet. Oral solution | 44098144/11.4.3/0981Approved 23 September 2021 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.